Deutsche Bank’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.69M Buy
91,421
+12,060
+15% +$876K ﹤0.01% 1143
2025
Q4
$5.99M Buy
79,361
+2,814
+4% +$177K ﹤0.01% 1233
2025
Q3
$3.04M Buy
76,547
+52,838
+223% +$2.02M ﹤0.01% 1535
2025
Q2
$1.03M Sell
23,709
-5,160
-18% -$196K ﹤0.01% 2076
2025
Q1
$1.08M Sell
28,869
-2,870
-9% -$111K ﹤0.01% 2112
2024
Q4
$1.44M Buy
31,739
+10,709
+51% +$546K ﹤0.01% 2043
2024
Q3
$1.24M Buy
21,030
+4,836
+30% +$232K ﹤0.01% 2021
2024
Q2
$637K Sell
16,194
-3,012
-16% -$146K ﹤0.01% 2219
2024
Q1
$1.28M Buy
19,206
+11,535
+150% +$504K ﹤0.01% 1882
2023
Q4
$214K Buy
7,671
+3,064
+67% +$61.4K ﹤0.01% 2838
2023
Q3
$98.1K Buy
+4,607
New +$101K ﹤0.01% 3168

Other funds holding APGE